Expression and clinical significance of MAPK and EGFR in triple‑negative breast cancer-Reference-Cited by-同舟云学术

Expression and clinical significance of MAPK and EGFR in triple‑negative breast cancer

Published:2020-01-09 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Jiang Weihua¹,Wang Xiaowen¹,Zhang Chenguang¹,Xue Laiti¹,Yang Liang¹

Affiliation:

1. Department of Breast Surgery, The 3rd Affiliated Teaching Hospital of Xinjiang Medical University (Affiliated Cancer Hospital), Urumqi, Xinjiang 830011, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advancement in developing small molecular inhibitors targeting key kinase pathways against triple-negative breast cancer;Bioorganic & Medicinal Chemistry;2024-10

2. Bioinformatics and computational studies of chabamide F and chabamide G for breast cancer and their probable mechanisms of action;Scientific Reports;2024-08-27

3. Investigating the potential of mono-chalcone compounds in targeting breast cancer receptors through network pharmacology, molecular docking, molecular dynamics simulation, antiproliferative effects, and gene expressions;3 Biotech;2024-05-10

4. Meta-analysis and network pharmacology-based investigation of Shenqi Fuzheng injection plus docetaxel for the efficacy and molecular mechanism of breast cancer;European Journal of Integrative Medicine;2024-04

5. Epidermal growth factor potentiates EGFR(Y992/1173)-mediated therapeutic response of triple negative breast cancer cells to cold atmospheric plasma-activated medium;Redox Biology;2024-02